A $50 Backdoor Play On Elon's Next "Super-IPO"?

Elon Musk has become Trump's most trusted advisors. According to one legendary investor... We are leading up to the world's first "Super-IPO" -- a company creating over $100 billion on the first day it goes public! Knowing about this "backdoor" play could be the best way to profit before the IPO...Starting with as little as $50.

BIIB
Biogen Inc
NASDAQ
205.6
Open 160.16 Prev Close 164.23
High 165.29 Low 160.16
Volume 1,663,600 Volume (Avg) 1,373,812
52 Week High 350.24 52 Week Low 223.25
Market Cap 40B PE Ratio 25.74

About Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB111 and BIIB112 to treat ophthalmology related diseases; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and TMS-007 to treat acute neurology; BIIB074 and BIIB095 for neuropathic pain; and SB11 and SB15 biosimilars, which are under various stages of development. The company offers products through its sales force and marketing groups. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; and Ionis Pharmaceuticals, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

General

NameBiogen Inc
TickerBIIB
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers-General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees9,100

Highlights

Analyst Target289.76
Market Cap39,953,162,240
PE Ratio25.74
PEG Ratio6.24
EBITDA5,112,500,224

Share Stats

Shares Outstanding153,882,000
Shares Float151,298,325
Shares Short3,571,963
Insider Holdings63%
Institution Holdings87.89%

Highlights

Analyst Target289.76
Market Cap39,953,162,240
PE Ratio25.74
PEG Ratio6.24
EBITDA5,112,500,224

Valuation

Trailing PE10.58
Forward PE14.01
Price/Sales (Trailing 12 Mt.)3.17
Price/Book (Most Recent Quarter)3.76

Earnings

Most Popular

44 years after New York couple vanished, car matching description of theirs is found in Georgia

BRUNSWICK, Georgia (AP) — A car similar to one driven by a wealthy New York couple missing for more than four decades has been found in a south Georgia pond near the hotel where they were last seen, police in Georgia said.

At the crossroads of news and opinion, 'Morning Joe' hosts grapple with aftermath of Trump meeting

One of the striking things about how furiously many people reacted to the news last week that MSNBC “Morning Joe” hosts Joe Scarborough and Mika Brzezinski was how quaint their defenders sounded.

Has the Tech Stock Selloff Finally Arrived? - Ad

After soaring over 150% in 2024 alone... is it actually time to buy Nvidia? A 50-year Wall Street veteran gives his answer to Nvidia, right here...Including the name and ticker of one under-the-radar AI stock to buy instead of Nvidia... before Tuesday, December 3rd.

Firm Issues Rare "All In" Buy Alert on $6 Gold Stock - Ad

The bull market in gold is just getting started...In fact, many top analysts are predicting gold could go much, much higher. But you should NOT just rush out and buy gold bars or coins. We've found a gold play that's much better...And priced at $6 today, this stock has tremendous upside potential as the price of gold continues to rise.

Stocks to Buy (and Sell) Before Inauguration Day

Experts predict Trump's policies will positively affect energy, finance, defense sectors; stocks to buy include EPD, JPM, LMT, while others may decline.

US commits to $7.54 billion loan for Stellantis venture to build 2 electric vehicle battery plants

DETROIT (AP) — A Stellantis joint venture with Samsung SDI has won a commitment from the U.S. government for up to a $7.54 billion loan to help build two electric vehicle battery plants in Kokomo, Indiana.

Why Is This Bull Run Scaring JP Morgan, Goldman Sachs, and Warren Buffett? - Ad

Billionaires Warren Buffett, Stanley Druckenmiller, and David Tepper have all sold off massive U.S. stock positions. Billionaire Ray Dalio, who runs one of the world's most successful hedge funds, says, "Things are going to get worse for our economy." What are these billionaires so worried about?

Dogecoin Is 'Harder Money' Than Bitcoin, Says Raoul Pal: Here's What The Numbers Say

Dogecoin (CRYPTO: DOGE) rallied 17% over the past week, spurred by speculation around Elon Musk's X Payments platform potentially incorporating DOGE.

Radical Jaguar rebrand and new logo sparks ire online

NEW YORK (AP) — A for a rebrand of British luxury car brand Jaguar is being criticized online for showing models in brightly colored outfits — and no car.

Former Trump Advisor: "This Could Destroy Families" - Ad

A huge change is coming to America, and it scares the life out of former Trump advisor Brad Thomas. He calls it "America's next big economic crisis" and warns it will forever reshape our country, potentially destroying lives and ripping families apart. And according to him, even President Trump can't stop it.

What will happen to CNBC and MSNBC when they no longer have a corporate connection to NBC News?

Comcast's means that there will soon be two television networks with “NBC” in their name — CNBC and MSNBC — that will no longer have any corporate connection to NBC News.

Wall Street Warns: Stocks Could Be "Dead Money" for Next 10 Years - Ad

Well-connected billionaires like Warren Buffett have been selling off US stocks at an alarming rate. Today, one of America's most trusted market experts is stepping forward to explain what's really going on behind the scenes of this bull market - and why you could soon face losses of 50% or more if you do nothing.

What to know about Scott Bessent, Trump's pick for treasury secretary

WASHINGTON (AP) — has chosen money manager Scott Bessent, an advocate for deficit reduction and deregulation, to serve as his next treasury secretary.

Stock Of The Day: Is Pfizer Set Up To Rally?

Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.

Elon Musk Is in Trump's "Inner Circle" - Ad

Elon Musk is one of Donald Trump's closest allies. James Altucher says that what Elon has planned next could lead to the world's first "Super-IPO" -- creating $100 billion on the first day it goes public! This "backdoor" play could be the best way to profit before the IPO...Starting with as little as $50.

Ted Cruz Says Running DOGE Won't Be A Cake Walk, Offers Reading Advice To Elon Musk

Senator Ted Cruz (R-Texas) anticipated the newly established Department of Government Efficiency (DOGE) department to yield “good results” but warned that Elon Musk and Vivek Ramaswamy would have their work cut out.

UPS to pay $45M to US settle charges that it improperly valued its freight division

UPS will pay $45 million to settle charges that it improperly valued its freight division, the Securities and Exchange Commission announced Friday.

Crypto Stocks Are Heating Up - Ad

At the center of this transformation is a game-changing platform that's experiencing explosive growth with $41 million in revenue in just nine months. The stock has doubled in the last 45 days, but this is only the beginning.

Trump's treasury pick could give an indication of what he plans to do about tariffs

WASHINGTON (AP) — President-elect Donald Trump’s decision on a treasury secretary is about far more than whose name will be printed on America’s money.

He'll be the last meatpacker in the Meatpacking District. Here's how NYC's gritty 'hood got chic

NEW YORK (AP) — When John Jobbagy’s grandfather immigrated from Budapest in 1900, he joined a throng of European butchers chopping up and shipping off meat in a loud, smelly corner of Manhattan that New Yorkers called the Meatpacking District.

Analysts Are Projecting "Safe-Haven" Stock Will Nearly Double - Ad

Already up nearly 50% in the last 6 months this gold company has an analyst target nearly twice its current price. With 45 investment banks and funds already invested it's no wonder this $1.3B company (trading under $2) is grabbing investor attention.

Trump's threat to impose tariffs could raise prices for consumers, colliding with promise for relief

DETROIT (AP) — If Donald Trump makes good on his threat to slap 25% tariffs on everything imported from Mexico and Canada, the price increases that could follow will collide with his campaign promise to give American families a break from inflation.

Will President Trump's "MAGA-Secret" Ignite Stocks in 2025? - Ad

It's responsible for the biggest wins in stock market history. It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge. Of course, most people don't know how this pattern works. But millionaire-trader Jeff Clark has used it for 40 years to generate over 1,000 winning trade recommendations.

Cannabis Could Save $29 Billion Per Year In U.S. Healthcare Costs, Says CEO

Leafwell CEO Emily Fisher reveals medical cannabis could save U.S. healthcare $29 billion annually, citing new research.

Chipotle Rival CAVA Surges Over 17% As Q3 Earnings Beat Expectations And Full-Year Outlook Improves

The fast-casual chain, known for its Mediterranean-inspired cuisine, reported earnings of 15 cents per share, surpassing the analyst consensus of 11 cents.

Donald Trump Can't Save You From This Crisis - Ad

A huge economic crisis is about to strike America. 12 months from today, our country could be unrecognizable. That's why I've recorded this video and released it for free. Inside, I lay out exactly what's happening and several critical moves I believe every American should make right now.

Internet entrepreneur Kim Dotcom has suffered a serious stroke, a post on his X account says

WELLINGTON, New Zealand (AP) — Kim Dotcom, the internet entrepreneur fighting deportation from New Zealand to the United States on charges relating to his file-sharing website Megaupload, has suffered a “serious stroke”, a post on his X account said Monday.

Mike Tyson Discloses Near-Death Experience Before Jake Paul Fight

In a shocking revelation, boxing legend Mike Tyson disclosed that he had a near-death experience just months before his fight with Jake Paul.

Elon's New Tech Could Be Bigger Than Tesla & SpaceX... Combined - Ad

Forget rockets or brain implants... Elon's new AI product could be his biggest invention yet. Jeff Brown tried it himself recently and caught his experience on camera. See this footage because according to Tesla Magazine, this new product "could well shape the technological and economic future of our society."

Crypto Analyst Sees Shiba Inu Surging More Than 2,000% In Coming Rally

A market analyst says Shiba Inu (CRYPTO: SHIB) could experience a massive rally, predicting gains exceeding 2,000%. What Happened: The forecast has sparked excitement among the cryptocurrency's community as SHIB continues to gain traction as a leading meme coin.

Federal Reserve's likely slowdown in rate cuts could disappoint borrowers

WASHINGTON (AP) — Just a few weeks ago, the path ahead for the Federal Reserve looked straightforward: With inflation cooling and the job market slowing, the Fed appeared on track to steadily cut interest rates.

The Same "Magic Pattern" That Predicted Trump's Win Now Predicts These Niche-Trades Will Surge! - Ad

It's responsible for the biggest wins in stock market history. It predicted Trump's sweeping victory. And now, this pattern says a handful of niche-sectors are poised to surge. Of course, most people don't know how this pattern works. But millionaire-trader Jeff Clark has used it for 40 years to generate over 1,000 winning trade recommendations.

Trump Responds 'TRUE!' To Conservative's Claim That Military Will Be Used Against Immigrants

Twice-impeached Trump often makes graphic criticisms of migrants, including unsubstantiated claims that linked them to crime and violence.

Tech Funds Are Hemorrhaging Cash: Sell This Stock Now - Ad

U.S. technology funds are HEMORRHAGING cash. It's the biggest selloff since the 2022 bear market. A 50-year Wall Street veteran just explained everything you need to know. For now, he's pounding the table on the No. 1 tech stock to BUY before 2024 comes to an end... And the No.1 tech stock Wall Street says to sell NOW.

BlackRock Set To Acquire Private Credit Manager HPS For $12B: Report

BlackRock, the world's largest asset manager with $11.5 trillion in assets, is finalizing a deal to acquire HPS Investment Partners, a prominent private credit firm managing nearly $150 billion.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service